Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam, Collaborators Report on RNAi Enhancement of Dendritic Cancer Cell Vaccine
August 23, 2012
Alnylam, Collaborators Report on RNAi Enhancement of Dendritic Cancer Cell Vaccine
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Alnylam to Release Phase II ATTR Data, Launch Expansion Trial in Coming Months
May 9, 2013 / Gene Silencing News
Tekmira Provides Pipeline Update, Eyes Agricultural Market
February 14, 2013 / Gene Silencing News
Alnylam Publishes Phase I Data on Liver Cancer Drug
January 31, 2013 / Gene Silencing News
Alnylam Adds New Program to Pipeline as It Shelves Anemia Candidate
January 10, 2013 / Gene Silencing News
Alnylam Forms Alliance with Genzyme in ATTR, Adds Another Notch to Partnership Belt
October 25, 2012 / Gene Silencing News